Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer

por Zhenghang Wang, Chang Liu, Yuezong Bai, Xiaochen Zhao, Longgang Cui, Zhi Peng, Xiaotian Zhang, Xicheng Wang, Zhengyi Zhao, Jian Li, Lin Shen
Publicado 2021

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer

por Xi Jiao, Xin Wei, Shuang Li, Chang Liu, Huan Chen, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yujiao Wang, Yanni Wang, Na Zhuo, Henghui Zhang, Zhihao Lu, Lin Shen
Publicado 2021